Seda Packaging Group: Revolutionary New Paper Lid Delivers Integrated Sustainable Drinking Solutions
23.1.2025 06:00:00 CET | Business Wire | Press release
Seda International Packaging Group’s versatile new EcoFit Lids offer complete plastic reduction and the lowest energy and water consumption manufacturing process
In a radical development significantly advancing sustainability, Seda International has proudly introduced its innovative EcoFit Lid on the market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250122180654/en/

The compostable Double Wall cold cups with EcoFit lids for a superior beverage experience (Photo: Luciano Romano)
The EcoFit Lid has been thoughtfully designed to completely replace traditional plastic lids with a leak- and spill-resistant solution that delivers a superior drinking experience for hot and cold beverages alike. Enhancing safety, an audible snap confirms it has engaged fully with the cup rim for a secure, tight fit that’s better both in-store and during delivery.
Conceived following Seda’s rigorous ecodesign principles, the EcoFit Lid is also an exceptionally flexible and versatile solution. Available in Flat & Domed options, each offers a choice of triangular or oval sip hole with either a C-cut, cross-cut or Push & Lift action to provide a fully-tailored consumer experience and brand personality.
Crafted from 100% certified renewable fibres, the EcoFit lid can be combined with Seda’s cutting-edge printing technology to offer exceptional branding opportunities. It has the lowest environmental impact of any fibre lid in terms of CO₂ Emissions and Water Consumption for the entire supply chain, from cradle to grave.
A Life Cycle Assessment (LCA) conducted using EU data has conclusively demonstrated the EcoFit lid's superiority over other lid options, including moulded fibre and plastic PS and PP lids. This was confirmed by a recent Seda gate-to-gate screening showing EcoFit’s substantial environmental benefits, including significantly lower production cycle water and energy consumption as well as carbon emissions than even moulded fibre lids.
Fully recyclable in the paper stream and also available in a compostable version to meet all needs and usage scenarios, the EcoFit Lidis set to massively reduce the depletion of fossil resources caused by current plastic lids, saving 400 tons of plastic for every 100 million lids.
Brands can consequently make measurable progress towards reducing their environmental impact by choosing EcoFit Lids to support their sustainability goals and contribute to a lower carbon footprint in the packaging supply chain.
Equally important, the EcoFit Lid is not an isolated solution but has been expressly designed to form an integrated, fully sustainable package with Seda’s Double Wall cups. An original Seda innovation developed for hot beverages and patented in the early 2000s, the Double Wall Cup has set the industry standard ever since.
Seda’s more recently introduced Double Wall Cold Cups are made from the same sustainable, printable paperboard and have likewise been conceived to deliver a superior drinking experience. Their unique, patented air gap design ensures beverages stay cold for longer, while greatly reducing condensation and sweating to provide a much more enjoyable tactile sensation compared with single wall cold cups made of paper or plastic. Consumers appreciate how their drinks remain cool and satisfying without worrying about condensation or slippery cups, making each sip as refreshing as the first.
These cups and lids have been specifically designed to meet the growing demands of evolving legislation across Europe that increasingly favours sustainable packaging solutions. Seda’s new offering thus provides a transformative solution for businesses that need to rapidly adapt to new environmental regulations.
“Our new EcoFit Lids and compostable Double Wall cold cups underscore Seda Group’s dedication to continuous innovation and sustainability,” said Armando Mariano, Director of Innovation, R&D, Materials, and Sustainability at Seda Group. “These products were designed with the future in mind, addressing environmental concerns and evolving consumer demands. By significantly reducing water consumption and CO2 emissions, our EcoFit Lid sets a new benchmark in sustainable beverage packaging. We are proud to offer solutions that not only comply with stringent regulations but also enhance the consumer experience while helping brands make meaningful progress towards their sustainability goals.”
As European consumers increasingly demand more sustainable products, Seda continues to lead the market with the most innovative and sustainable packaging solutions, consistently delivering top-quality products that meet customer expectations with outstanding service.
Leading coffee, restaurant, and convenience store brands worldwide are already adopting these innovations to meet their sustainability objectives.
Seda International Packaging Group is a leading provider of sustainable food and food service packaging solutions. Headquartered in Naples, Italy, Seda operates manufacturing platforms across Italy, Germany, Portugal, the UK and North America.
Discover more about Seda at www.sedagroup.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250122180654/en/


Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release
The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom